Bringing the fundamentals into focus…
Back to Turn Therapeutics Inc.
How Turn Therapeutics Inc. stacks up
TTRX · against 589 other Healthcare companies listed in US-listed
Valuation
8/ 100
Near the bottom of its peers.
Ranked #314 of 590 · scores higher than 3% of peers
Bars: peers in each 10-point band of the valuation score277 peers with a valuation score of 0–9, including TTRX · Click a bar to see the companies
Why valuation scores 8?
Weighted metrics compared with all Healthcare companies.Mainly because of its EBITDA yield and earnings yield, which are weaker than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. EBITDA yield: -2.6% vs peer median 3.9%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -3.2% vs peer median 1.4%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -1.6% vs peer median 0.0%
Metric by metric
Position: dot = TTRX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | TTRX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | -3.1% | -4.4% | 53% | 30% | |
| EBITDA yieldHigher is better · 578 reported | -3.3% | -0.8% | 43% | 50% | |
| Free cash flow yieldHigher is better · 554 reported | -1.6% | -2.3% | 52% | 20% | |
| Book yieldHigher is better · 587 reported | 0.3% | 26.6% | 10% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around TTRX| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 253M USD | 98 | 80 | |
| 2 | 2.2B USD | 97 | 97 | |
| 3 | 563M USD | 96 | 97 | |
| 3 | 408M USD | 96 | 81 | |
| 3 | 322M USD | 96 | 57 | |
| 314 | 513M USD | 8 | 31 | |
| 314 | 2.1B USD | 8 | 23 | |
| 314 | 1.8B USD | 8 | 42 | |
| 314 | 1.3B USD | 8 | 44 | |
| 314 | 271M USD | 8 | ||
| 314 | 8.0B USD | 8 | 29 | |
| 314 | 7.6B USD | 8 | 28 | |
| 314 | 1.4B USD | 8 | 39 | |
| 314 | 1.3B USD | 8 | 31 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score